Anna Farago und Cancer - Info zur Person

(1 - 12 von 15

)

PharmaMar Announces That the ATLANTIS Study Has Reached the Goal of...

www.finanznachrichten.de

MADRID, July 31, PRNewswire/ -- ATLANTIS study, in small-cell lung cancer with lurbinectedin, recruited 600 patients in a total of 160 hospital centers...

Dr. Anna Farago, Hematologist in Boston, MA | US News Doctors

health.usnews.com

Dr. Anna Farago is a hematologist in Boston, Massachusetts and is affiliated with multiple hospitals in the area, including Dana-Farber Cancer Institute and ...

Anna Farago, MD, PhD | Authors - Targeted Oncologywww.targetedonc.com › authors › anna-farago-md-...

www.targetedonc.com

Anna Farago, MD, PhD, assistant, medicine, Massachusetts General Hospital, discusses challenges in treating small cell lung cancer.

PharmaMar is present with its ATLANTIS study at the IASLC …

pharmamar.com

WebStudy of Lung Cancer (IASLC). During this meeting, Anna Farago M.D., Ph.D., co-Principal Investigator of the ATLANTIS trial from Massachusetts General Hospital in Boston, …

UALC - Massachusetts General Hospital - Anna Farago, MD, PhD -...

www.lungcancerresearchfoundation.org

Anna Farago, MD, PhD. Massachusetts General Hospital. Research Project: Leveraging genetically engineered mouse models of small cell lung cancer for ...

Dr. Anna Farago, MD – Boston, MA | Oncology

www.doximity.com

Dr. Anna Farago, MD is an oncologist in Boston, Massachusetts. She is affiliated with Massachusetts General Hospital and Dana-Farber Cancer Institute.

Durvalumab Plus-Chemotherapie verbessert das Überleben ...

immuntherapiekrebs.de

Obwohl die Verbesserung des Überlebens mit Immuntherapie bescheiden war, ist es bemerkenswert, weil SCLC eine so widerspenstige Krankheit war, sagte Anna Farago, MD, Ph.D., eine Lungenkrebsspezialistin am Massachusetts General Hospital Cancer Center, die nicht an der Behandlung beteiligt war Versuch.

Coordinating center for the NCI small cell lung cancer research...

grantome.com

Anna Farago and Jeff Engelman at MGH, together with John Poirier and Dr. Rudin at MSK, have established substantial resources of SCLC patient- derived ...

A Study Exploring Olaparib and Temozolomide in Small Cell Lung Cancer

www.targetedonc.com

▶ 2:49Anna Farago, MD, PhD, discusses a phase I study of olaparib (Lynparza) and temozolomide (Temodar) in ...

Dr. Farago on Combination of Olaparib and Temozolomide in Small Cell...

www.onclive.com

Anna Farago, MD, PhD, assistant, Medicine, Massachusetts General Hospital Cancer Center, and instructor, Medicine, at Harvard Medical ...

Just a moment...

www.ilcn.org

By Anna Farago, MD, PhD. Small cell lung cancer (SCLC) accounts for approximately 15% of all new lung cancer diagnoses in the United ...

Combining Forces in Small Cell Lung Cancer

www.curetoday.com

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

Alle Infos zum Namen "Anna Farago"

Verwandte Suchanfragen zu Anna Farago

Personen
Vorname "Anna" (67621)
Name "Farago" (147)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Anna Farago und Cancer Person-Info